Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.34 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | LPL | P06858 | 1/20 | 0.31 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5167580 | 0.90 | CNR1 (0.41) | CNR1CNR2NPC1TP53PKM | |
| SCHEMBL14634131 | 0.89 | CNR1 (0.44) | CNR1CNR2ALOX5NPC1TP53 | |
| SCHEMBL9664336 | 0.83 | ALOX5 (0.41) | CNR1CNR2HTR2AHTR2CALOX5 | |
| SCHEMBL27882299 | 0.79 | SKP2 (0.46) | HTR2AHTR2CNPC1TP53RAB9A | |
| SCHEMBL9664848 | 0.79 | TAAR1 (0.40) | CNR1CNR2HTR2AHTR2CALOX5 | |
| SCHEMBL8990636 | 0.79 | MAOB (0.47) | HTR2AHTR2CNR3C2ALOX5NPC1 | |
| SCHEMBL7178106 | 0.79 | TAAR1 (0.51) | HTR2AHTR2CNR3C2 | |
| SCHEMBL15495007 | 0.78 | CNR1 (0.44) | CNR1CNR2S1PR1ALOX5NPC1 | |
| SCHEMBL13002672 | 0.78 | DAO (0.41) | CNR1CNR2HTR2AHTR2CS1PR1 | |
| SCHEMBL9664166 | 0.78 | RARB (0.46) | HTR2AS1PR1ALOX5HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6579577-B2 | High voltage holding ratio which has a very small degree of temperature dependence, a low threshold voltage | CHISSO CORPORATION (JP) | 2003-06-17 | — | — | US | disclosed |
| US-20020166994-A1 | Substituted benzene derivative, liquid crystal composition, and liquid crystal display element | CHISSO CORPORATION (JP) | 2002-11-14 | — | — | US | disclosed |
| EP-0934919-A1 | SUBSTITUTED BENZENE DERIVATIVE, LIQUID-CRYSTAL COMPOSITION, AND LIQUID-CRYSTAL DISPLAY ELEMENT | CHISSO CORPORATION (JP) | 1999-08-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020166994-A1 | Substituted benzene derivative, liquid crystal composition, and liquid crystal display element | OCIAD2, OCIAD1, POU2F1 | CNR1 1937/4885CNR2 1925/4885HTR2A 3146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.